No insider purchases or sales are on record for Akari Therapeutics Plc in the period covered. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see 2 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | — | — | $367.9K | $607.7K |
| OPERATING INCOME | $-17.3M | $-21.6M | $-16.8M | $-11.8M |
| NET INCOME | $-17.3M | $-19.8M | $-10.0M | $-13.1M |
| EPS (DILUTED) | 0.00 | 0.00 | 0.00 | -0.74 |
| OPERATING CASH FLOW | $-10.6M | $-12.6M | $-16.4M | $-7.5M |
| CASH | $0 | $0 | $3.8M | $13.2M |
No password to create and no card required. We store your email address and nothing else.